3.425
price up icon3.79%   0.125
after-market After Hours: 3.51 0.085 +2.48%
loading

Dare Bioscience Inc Stock (DARE) Financials Data

Income Statement
Quarterly
*All numbers in millions
Period End Date 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Period Length 3 Months 3 Months 3 Months 3 Months 3 Months
Revenues
99.49%
0.0093
1.8079 1.00 - -
Operating Expenses
13.58%
6.0318
6.9793 9.3964 8.9894 8.3826
Benefits Costs and Expenses
100.00%
-
32.97 - - -
Costs And Expenses
2.69%
6.0318
6.1985 9.3964 - -
Operating Income/Loss
16.46%
-6.0225
-5.1715 -8.3964 -8.9894 -8.3826
Income/Loss From Continuing Operations Before Tax
100.03%
0.0093
-31.16 1.00 -8.7622 -8.0425
Income/Loss From Continuing Operations After Tax
33.63%
-6.7554
-5.0552 -8.2991 -8.7622 -8.0425
Net Income/Loss
33.57%
-6.7554
-5.0576 -8.2991 -8.7622 -8.0425
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
122.29K%
100.51
0.0821 91.05 86.40 85.52
Diluted Average Shares
122.29K%
100.51
0.0821 91.05 86.40 85.52
Basic Earnings Per Share
16.67%
-0.07
-0.06 -0.09 -0.10 -0.09
Diluted Earnings Per Share
16.67%
-0.07
-0.06 -0.09 -0.10 -0.09
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$21.50
price up icon 1.61%
$74.59
price down icon 1.14%
$370.49
price down icon 2.02%
$43.06
price down icon 0.76%
$215.00
price up icon 4.29%
$118.39
price down icon 1.93%
Cap:     |  Volume (24h):